Now Enrolling!
iConquerMS is conducting the largest-ever study on a new therapy to combat MS fatigue
iConquerMS is partnering with the Department of Veterans Affairs (VA), GAIA AG (a digital therapy company), Charité – Universitatsmedizin Berlin, the University Medical Center Göttingen, and Ordinal Data, Inc., on a four-year, large-scale clinical trial of online programs, or digital therapeutics, for treating fatigue in MS.
This trial is funded by a nearly $4.5 million grant from the Department of Defense Congressionally Directed Medical Research Programs (CDMRP), Multiple Sclerosis Research Program (MSRP).
For many people living with MS, fatigue is a common symptom that limits their ability to engage in regular everyday activities. Affecting about 70 percent of people with MS, it accounts for a substantial portion of the disability and psychosocial burden of this disease. While medication-based treatments have had mixed results in studies and carry risks of side effects, analyses of a number of smaller studies show treatment with non-pharmacological approaches may be effective and safe.
The clinical trial will assess the effectiveness of an online program for MS fatigue and with the goal of gaining FDA approval of a novel, non-pharmacological fatigue therapy.
The large-scale, decentralized clinical trial is projected to enroll 2,000 people with MS. The collaboration between iConquerMS and 5 VA sites in the MS Centers of Excellence is designed to ensure sufficient representation of people living with MS from populations traditionally under-represented in MS clinical trials in order to increase generalizability of the study results.
iConquerMS members are part of a community that is making a difference! Not already an iConquerMS member? Please consider joining today. Together, we can make an even greater impact advancing relevant, participant-driven MS research!
